It appears there's another fly in the ointment for Big Pharma's billion dollar baby --
statin drugs. A new study finds an alarming increase of prostate cancer in overweight men who use statins long-term, boosting rates by 80% for those taking these drugs for 5 years or more. If your doctor tries to put you on statins, please realize that there are many serious side effects associated with these drugs, and yet many people are prescribed them for life! Besides the dangers, they often don't work as advertised, and can in fact even worsen your risk for cardiovascular disease.
If you have abnormally high cholesterol or other indicators of arterial inflammation, there are many safer, more effective ways to regain your health. Some of these include dietary and supplemental therapies such as flaxseed (and oil), oatmeal, fish oil (high in omega-3 fatty acids), exercise, and other lifestyle choices that will lead you towards wellness and away from disease. Don't fall for the statin scam. They're a huge moneymaker for the pharmaceutical companies, but they are no friend to your health.
Prostate cancer risk increased in obese men: study
By Michelle Rizzo
Fri Aug 22, 2:17 PM ET
Use of cholesterol-lowering statin drugs, especially long-term use, appears to raise the risk of prostate cancer among obese men, according to findings of a new study.
"Given the epidemic of obesity in the U.S. and the frequent use of statins, the positive association we observed raises substantial concern as to the safety of these widely prescribed agents," Dr. Janet L. Stanford of the Fred Hutchinson Cancer Research Center in Seattle and colleagues wrote in the American Journal of Epidemiology.
In a population-based, case-control study, the researchers matched 1,001 men with prostate cancer diagnosed between 2002 and 2005 with 942 age-matched cancer-free controls from King County, Washington.
No overall association was observed between the risk of prostate cancer and the current or past use of statin treatment. Duration of statin use was also not associated with prostate cancer risk.
"We also found no evidence that use of a statin was associated with risk of developing more aggressive subtypes of prostate caner," Stanford said in an interview with Reuters Health. "Overall we found no support for the current hypothesis that statin use may reduce risk of prostate cancer."
However, the results do suggest a significant increase in the risk of developing prostate cancer associated with current statin use and with longer durations of use among obese men (defined as a body mass index of 30 greater).
"Among obese men," Stanford told Reuters Health, "current use of a statin was associated with a 50 percent increase in risk of prostate cancer; and use for 5 or more years was associated with an 80 percent increase in risk of the disease; both of these risk estimates were statistically significant."
These findings warrant further investigation, she said.
http://news.yahoo.com/s/nm/20080822/hl_nm/prostate_risk_dc&printer=1;_ylt=An_n7K0dzWY.qS4Q_PM7LCUR.3QA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment